Clinical Pathways Congress 2018 has ended
avatar for Linda Bosserman, MD, FASCO, FACP

Linda Bosserman, MD, FASCO, FACP

Clinical Assistant Professor, City of Hope Medical Group, Inc., Duarte, California
Linda Bosserman, MD, FACP, graduated with highest honors in biochemistry from UC Berkeley, received her medical degree, completed an internship and residency in internal medicine, and served on the faculty at Stanford University. This was followed by oncology fellowships and faculty appointments at Harvard Medical School, Dana-Farber Cancer Institute and Brigham and Women's Hospital. She returned home to southern California in 1990 where she was a community medical oncologist with Wilshire Oncology for 26 years until the practice joined the City of Hope Medical Group in September of 2014. She focuses on breast oncology, international and telemedicine services as well as pathways and value based initiatives for the organization.

Dr. Bosserman served as President and managing partner of Wilshire Oncology for 15 years, focusing her leadership on piloting electronic tools, teamwork and care processes to implement oncology medical home models with clinical pathway use while participating in clinical trials through the UCLA, Sara Cannon, and US Oncology trial networks. As an ASCO member since 1990, Dr. Bosserman has served on many committees, task forces and two guideline panels. She is competing a 4 year term on the board of directors and has been chosen to succeed Dr. Cox as the next Editor in Chief of the Journal of Oncology Practice starting in 2019.

A long career as a practicing medical oncologist, practice manager and leader in oncology initiatives provided perspectives from all stakeholders in oncology. Watching the impact of scientific discoveries, as well as greater payer, administrative, regulatory and technology demands on clinicians led to interest in improving the tools and efficient use of them with teams to meet the growing need for value based care while also addressing the growing burnout crisis in oncology. Dr. Bosserman believes that understanding and developing solutions to maintain a healthy and energized work force empowered to provide personalized, precision oncology care and management while providing access to cutting edge clinical research is key to the successful transformation to value based oncology care.